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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S143became detectable, while Col10a1 mRNA was strongly increased, but to
a lesser extent in COG5-. Alizarin red was stronger in controls.
Conclusions: COG5 defect reduces the chondrogenesis process, despite
active BMP-Smad signaling. As COG5 also affected the expression and
glycosylation pattern of speciﬁcWnts, this underlines its critical role in the
fate of chondrogenic cells, and may point to a role in OA.
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SNORC, A NEW SPECIFIC MARKER OF HUMAN DIFFERENTIATED
ARTICULAR CHONDROCYTES
D. Ollitrault, Jr., F. Legendre, Jr., T. Gomez-Leduc, Jr., N. Bigot, Jr., S. Leclercq,
Sr., C. Bauge, Jr., K. Boumediene, Sr., M. Demoor, Sr., P. Galera, Sr., Lab. of
Cellular microenvironnement and pathologies (MILPAT), Caen, France
Purpose: Chondrocyte is the major cell type of cartilage and it synthesizes
an abundant extracellular matrix (ECM) that contains two main speciﬁc
markers, type II collagen and aggrecan. Other characteristic markers are
also expressed in cartilage, but their expression is less abundant than those
observed for type II collagen and aggrecan. These ECM components are
more present in the territorial or interterritorial matrix and, presently, no
speciﬁc marker of human cartilage have been identiﬁed on the membrane
of articular chondrocytes.
Methods: Snorc mRNA expression was studied by Q-RT-PCR in chon-
drocytes and during chondrogenesis induction in adult mesenchymal stem
cells (AMSCs) from bone marrow. The protein alignment of Snorc was
made with Geneious and the 3D modelisation was performed with the
iTASSER server from the Michigan University.
Results: In this study, we have analyzed a new speciﬁc marker of the
differentiated status of human articular chondrocytes (HACs). Snorc is
a small transmembrane proteoglycan (PG) composed of 121 amino acids.
We reported that its expression decreased when HACs are dediffer-
entiated by sub-culturing or upon IL-1b treatment. Conversely, Snorc
expression is increased during the redifferentiation of HACs by BMP-2 in
a 3D culture model in hypoxia. Furthermore, when chondrogenesis was
induced in human AMSCs, the expression of this PG is greatly enhanced,
as observed for type II collagen, aggrecan and SOX9. In addition, Snorc
seemed to be expressed in a tissue-speciﬁc manner because no expres-
sion was detected in the skin, bone and AMSCs. Finally, the transcription
activity of the SNORC gene could be regulated, indirectly or directly, by
several transcriptions factors involved in the transactivation of type II
collagen gene, such as Sp1, SOX9 and/or HIF-1a, whose each of them
present a putative DNA binding site in the SNORC proximal promoter. The
primary structure of Snorc and the modelization of its quaternary
structure in 3D were analyzed to compare this PG spatial organization
between Mouse and Human species. This approach reveals that Snorc
seems to conserve the same spatial organization and contains one or
probably two transmembrane domains, an extracellular and an intracel-
lular domain.
Conclusions: During the HACs dedifferentiation, Snorc mRNA levels are
decreased whereas they are increased during the redifferentiation of HACs
or during the induction of chondrogenesis in AMSCs from bone marrow.
Thus, these results allow us to consider Snorc as a new speciﬁc marker of
the human articular cartilage that should be evaluated in order to better
appreciate the differentiation status of chondrocytes. Moreover, Snorc
could play an important role in cartilage homeostasis by potentially
inducing an intracellular signalisation pathway or perhaps participating to
the territorial matrix anchoring.
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GLUCOSAMINE AND AN ITS PEPTIDYL-DERIVATIVE INFLUENCE
TNF-ALPHA ACTIVATION OF NF-kB PATHWAY
L. Politi, D. Stoppoloni, R. Scandurra, A. Scotto d'Abusco. Univ. of Roma,
Roma, Italy
Purpose: NF-kB transcription factor regulates several cell signaling path-
ways, such as differentiation and inﬂammation, which are both altered in
osteoarthritis. IKKa and IKKb are kinases involved in the activation of the
NF-kB transcription factor. The aim of the present study was to determine
the effects of glucosamine (GlcN), which is administered in the treatmentof osteoarthritis, and of its 2-(N-Acetyl)-L-phenylalanylamido-2-deoxy-b-
D-glucose (NAPA) derivative, synthesized in our laboratory, on IKK kinases
and, consequently, on NF-kB activation in human chondrocytes.
Methods: The human chondrosarcoma cell line HTB-94 and human
primary chondrocytes were stimulated with TNFa after pre-treatment
with GlcN or NAPA. Gene mRNA expression level was evaluated by Real
Time-PCR. IkBa phosphorylation and p65 nuclear re-localization were
analyzed by Western blotting, IKKa nuclear translocalization was also
investigated by immunocytochemistry and Western blotting. IKK kinase
activity was studied by in vitro kinase assay.
Results: After TNFa stimulation, the mRNA expression level of some of the
genes under NF-kB control, such as IL-6 and IL-8, increased, while treat-
ment with GlcN and NAPA reverted the effect. We investigated the
possibility that GlcN and NAPA inhibit IKK kinase activity and found that
NAPA inhibits the IKKa kinase activity, whereas GlcN does not. Interest-
ingly, both GlcN and NAPA inhibit IKKa nuclear re-localization.
Conclusions: Our results demonstrate that glucosamine and its peptidyl-
derivative can interfere with NF-kB signaling pathway by inhibiting IKKa
activity in human chondrocytes. However, the mechanism of action of the
two molecules is not completely overlapping. While NAPA can both
speciﬁcally inhibit the IKKa kinase activity and IKKa nuclear trans-
localization, GlcN only acts on IKKa nuclear translocalization.
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INDUCTION OF HIGH TEMPERATURE REQUIREMENT A1, A SERINE
PROTEASE, BY TGF-BETA1 IN KNEE JOINTS OF MOUSE MODELS OF OA
Y. Li 1, I. Golshirazian 2, B.J. Asbury 2, J. Kim 2, L. Xu 1. 1Harvard Med. Sch.,
Boston, MA, USA; 2Harvard Sch. of Dental Med., Boston, MA, USA
Purpose: High temperature requirement A 1 (HTRA1), a serine protease,
has been implicated as a possible factor in the pathogenesis of osteoar-
thritis (OA) and rheumatoid arthritis (RA). In this study we examined the
effects of high temperature, tumor necrosis factors alpha (TNFa), trans-
forming growth factor beta 1 (TGF-b1), and a high hydrostatic pressure on
the induction of HTRA1 in chondrocytes.
Methods: Cell culture- Human primary chondrocytes were grown in the
medium supplemented with 10% FBS. Cells were then divided into
a control group or one of four experimental conditions: heating to 42oC,
addition of recombinant human TNFa (10ng/ml), addition of recombinant
human TGF-b1 (10ng/ml), or high hydrostatic pressure (5,000 psi ¼
34 MPa). Cells were then lysed with subsequent RNA extraction. Ex vivo
articular cartilage culture of mouse hip- Hip articular cartilage from six 10-
week old C57BL mice were pooled and homogenized with PT-DA 2112/EC
polytron at the lowest speed for 30 seconds. The sample was ﬁltered
through a 100 mmNylon Cell Strainer. The ﬁltered sample was re-dissolved
in 1ml of DMEM and divided into twowells. The samplewas cultured with
or without TGF-b1 (10ng/ml) for 6, 12 and 24 hrs at 37 oC. The cartilages
were then collected for isolation of total RNAs. Real-time PCR- cDNAs were
synthesized with total RNAs from the cultured human chondrocytes and
mouse hip cartilages. The level of HTRA1 in the samples was examined. A
cDNA sample in each experiment was tested in triplicate and each
experiment was performed twice. Immunohistology- The expression of
TGF-b1, p-Smad1 and p-Smad2 in Col11a1+/- mice at the age of 10 weeks
(a genetic form of mouse model of OA) and mice with surgical destabili-
zation of the medial meniscus (DMM, a non-genetic form of model of OA)
were examined (n¼4 in each experimental group). Parafﬁn sections were
incubated with polyclonal antibodies against TGF-b1, p-Smad1, and p-
Smad2. After overnight incubation at 4C, the sections were treated with
a biotinylated secondary antibody and peroxidase substrate. Staining with
isotype-matched normal IgG and staining without primary antibody were
also performed as negative controls. Intra-articular injection of a neutral-
izing TGF-b1 antibody into mice knee joints- The neutralizing TGF-b1
antibody (25 mg) or PBS as control was injected into the cavity of knee
joints of Col11a1+/- mice at the age of 10 weeks. An additional injection
was performed 2 weeks later. Knee joints were collected 2 weeks after the
second injection. Expression proﬁles of p-Smad2 and HtrA1 were exam-
ined by double immunohistostaining. Double immunohistostaining-
Sections from Col11a1+/- mice treated with the neutralizing TGF-b1
antibody, and DMM mice were incubated with primary polyclonal anti-
bodies against p-Smad2 and HtrA1 at 4C overnight. The sections were
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anti-rabbit IgG and Alexa Fluor594 donkey anti-goat IgG for 30 min.
Results: There were no signiﬁcant differences in the level of HTRA1 mRNA
between control and experimental chondrocytes treated with 42oC, TNFa,
or the high hydrostatic pressure. In contrast, the level of HTRA1 mRNA
increased by w5-fold in human chondrocytes treated with TGF-b1. The
level of HtrA1 mRNA was also increased in mouse chondrocytes treated
with TGF-b1. Expression of p-Smad1 was hardly detected in Col11a1+/-
and DMM mice and corresponding control mice. However, the expression
of Tgf-b1 and p-Smad2 was increased. The increased expression of
p-Smad2 and HtrA1 was co-localized in Col11a1+/- and DMM mice.
Interestingly, expressions of p-Smad2 and HtrA1 were hardly detected in
Col11a1+/- mice treated with the neutralizing TGF-b1 antibody.
Conclusions: These results indicate that TGF-b1 may induce HTRA1 in
chondrocytes. Therefore, current OA therapy using TGF-b1 may be con-
traindicated as it may do more harm than good in the protection of
articular cartilage against OA in matured joints.
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IKKa MODULATES OXIDATIVE STRESS-INDUCED DNA DAMAGE AND
REPAIR IN PRIMARY HUMAN OA CHONDROCYTES
S. Neri 1, S. Guidotti 1, D. Platano 1, E. Olivotto 1, A. Facchini 1,2,
K. Marcu 1,3, R. Borzì 1. 1 Lab. Immunoreumatologia e rigenerazione
tissutale/RAMSES, Istituto Ortopedico Rizzoli, Bologna, Italy; 2Dip. Med.
Clinica, Università di Bologna, Bologna, Italy; 3Biochemistry and Cell
Biology Dept., Stony Brook Univ., Stony Brook, 11794-5215, New York, NY, USA
Purpose: Functional derangement of osteoarthritic chondrocytes make
them more susceptible to stressful conditions such as oxidative stimuli
within aging tissue, which can further provoke extrinsic senescence by
DNA damage responses (DDR). Our previous observation that IKKa
knockdown increased the replicative potential of primary human OA
chondrocyte monolayer cultures and the survival of the same cells
undergoing hypertrophic-like differentiation, prompted us to investigate
whether IKKa knockdown could modulate the stress-induced senescence
of OA chondrocytes as assessed by their DDR.
Methods: We assessed the effects of IKKa loss on ROS-induced DDR by
exposing control and IKKa KD chondrocytes (derived from 10 patients) in
low density in monolayer cultures to 1 hr of 100 mM hydrogen peroxide
and then scored them for their relative degrees of microsatellite instability
(MSI) and double strand breaks (DSB).
Mismatch repair (MMR), the main post-replicative correction pathway has
a fundamental role in maintaining genomic stability and its efﬁciency can
be monitored by assessing MSI. Part of the cells, left untreated or exposed
to 100 mM H2O2, were collected after 6 hour recovery to evaluate MMR
enzymes (i.e., MLH1, MSH2, MSH6, MSH3, PMS1 and PMS2) mRNA
expression by quantitative RT-PCR using GAPDH as a reference control.
Other cells were further cultured for 72 hours and analyzed for MSI at ﬁve
different genomic DNA loci (CD4,VWA, FES, TPOX, and P53).
DDR was evaluated in cells immediately after H2O2 exposure by ﬂow
cytometric analysis for gH2AX foci in chromatin. gH2AX foci serve as
a marker of double strand breaks representing sites of H2AX phosphory-
lation, which can subsequently lead to the recruitment of DNA repair
factors.
Results: Real time PCR data show increased expression of MSH3 and PMS1
mRNAs in IKKa KD chondrocytes after H2O2 exposure. MSI was detected in
control cells but not in their IKKa KD counterparts. Under basal conditions,
preliminary ﬂow cytometry results indicate the comparable presence of
gH2AX DNA foci in IKKa KD and controls in 6 out of 7 patient chondrocytes.
However, after H2O2 exposure, preliminary results indicate a higher
percentage of gH2AX positive cells and more foci per cell in the absence of
IKKa.
Conclusions: Thus far our preliminary data indicate that IKKa controls the
intensity of primary human OA chondrocyte DDR induced by oxidative
stress. Thus IKKa loss appears to increase cell susceptibility to ROS-
mediated DDR as indicated by their augmented DSB induction, perhaps
due in part to the faster doubling time of IKKa deﬁcient cells. However, MSI
and MMR gene expression data suggest that IKKa deﬁcient primary OA
chondrocytes also possess a higher capacity to repair DNA damage. More
experiments are underway to conﬁrm and extend our results with cells atcomparable passage numbers to determine if H2O2-mediated stress
induces these effects or exacerbates a pre-existing physiological state
reﬂecting the faster division rate of IKKa compromised cells.
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AN INVESTIGATION OF THE EFFECT OF EXOGENOUS GROWTH FACTOR
GDF5 ON PRIMARY OA CHONDROCYTES - IS THERE A PREDICTABLE
RESPONSE?
M. Ratnayake 1, F. Plöger 2, M. Santibanez-Koref 1, J. Loughlin 1. 1Newcastle
Univ., Newcastle upon Tyne, United Kingdom; 2Biopharm GmbH, Heidelberg,
Germany
Purpose: A genetic deﬁcit mediated by SNP rs143383 and involving
reduced expression of the growth differentiation factor 5 gene GDF5 is
strongly associated with large-joint OA. We speculated that this deﬁcit
could be attenuated by the application of exogenous GDF5 protein and as
a ﬁrst step we have assessed what effect such application has on primary
OA chondrocyte gene expression.
Methods: Chondrocytes were isolated from the cartilage of OA patients
who had undergone elective surgery of the hip or knee and cultured in the
presence of 100ng/ml of wild-type recombinant human GDF5 protein for
6, 12, 24 and 48 hours. We also studied variants of GDF5 that have a higher
afﬁnity for the BMP Ia receptor, which is highly expressed by chondrocytes.
As a positive control, chondrocytes were treated with TGFb, which is
known to elicit a predictable anti-catabolic response. The expression of
genes coding for catabolic, anti-catabolic, and structural proteins of
cartilage were measured by quantitative PCR (qPCR).
Results: The expression of the relevant GDF5 receptor genes BMPRII,
BMPRIA and BMPRIB was conﬁrmed by qPCR. The capacity of GDF5 to
initiate cell signaling in chondrocytes was demonstrated by the phos-
phorylation of intracellular SMADs, and the ability of the signal to then
translocate to the nucleus was demonstrated by the activation of a lucif-
erase reporter construct harbouring SMAD response elements. Chon-
drocytes cultured with TGFb demonstrated a consistent down-regulation
of the catabolic metalloproteinase genes MMP1 and MMP13, of the carti-
lage differentiation transcription factor gene SOX9, and of the aggrecan
gene ACAN. They also showed a consistent up-regulation of TIMP1, which
codes for an inhibitor of MMPs, and of the cartilage type II collagen gene
COL2A1. In contrast, chondrocytes cultured with wild-type GDF5, or its
variants, did not show any consistent response, with variation observed
relative to the length of time of culture, and with an inconsistent response
between individuals irrespective of the donor's sex or of the original site of
the chondrocytes (hip or knee).
Conclusions: OA chondrocytes do not respond in a predictable manner to
culture with exogenous GDF5. This may be a cause or a consequence of the
OA disease process and will need to be surmounted if treatment with
exogenous GDF5 is going to be advanced as a potential means of alleviating
the genetic deﬁcit mediated by OA susceptibility at the gene GDF5.
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THE ROLE OF NOREPINEPHRINE IN HUMAN ARTICULAR
CHONDROCYTES
J. Kaps 1,2, R.H. Straub 3, M. Böhm4, J. Beckmann 2, J. Grifka 2,
S. Grässel 1,2. 1 Experimental Orthopedics, Ctr. for Med. Biotechnology,
BioPark1, University of Regensburg, Germany; 2Orthopaedic Surgery,
University of Regensburg, Germany; 3Dept. of Internal Med., exp.
Rheumatology and Neuroendocrine-Immunology, University of Regensburg,
Germany; 4Dept. of Dermatology, Lab. for Neuroendocrinology of the Skin
and Interdisciplinary Endocrinology, University of Münster, Germany
Purpose: Norepinephrine belongs to the catecholamine family of tyrosine-
derived neurotransmitters of the sympathetic nervous system. Tyrosine-
hydroxylase positive sympathetic nerve ﬁbers have been identiﬁed in bone
marrow, in the periosteum and in bone-adherent ligaments indicating that
growth and metabolic activity of bone and joint tissues is regulated by
sympathetic neurotransmitter. It is known that norepinephrine can
regulate cell proliferation or apoptosis in several cell types, such as oste-
oblasts. It is further described that norepinephrine modulates inﬂamma-
tion during rheumatoid arthritis and gut inﬂammation. Here, we aim to
